Trademark: 87048025
Word
MOLECULAR HEALTH MH GUIDE
Status
Registered
Status Code
700
Status Date
Tuesday, September 18, 2018
Serial Number
87048025
Registration Number
5566271
Registration Date
Tuesday, September 18, 2018
Mark Type
3000
Filing Date
Tuesday, May 24, 2016
Published for Opposition
Tuesday, May 16, 2017

Trademark Owner History
Molecular Health GmbH - Original Registrant

Classifications
9 Downloadable computer databases containing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology; downloadable computer databases containing medical and health information on humans; downloadable computer software for accessing, organizing, indexing, ranking, integrating, linking, referencing, synthesizing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, pharmaceuticals, life sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for mobile devices, for accessing, organizing, synthesizing, indexing, ranking, integrating, linking, referencing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for accessing databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology
38 Providing access to searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and medical and health information and records, molecular test results and patient specific data about or relating to humans for scientific research purposes; providing access to online databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and medical or health information or records about or relating to humans and patient specific data, molecular test results, and scientific research for medical diagnostic and treatment purposes; providing access to online software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing access to non-downloadable computer software and algorithms for medical diagnostic and treatment purposes
44 Medical consulting services, namely, the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; consulting services in the fields of medical care, pharmaceuticals and medicine; providing medical information in the fields of health, healthcare, life sciences, biotechnology, pharmaceuticals and pharmaceutical safety, bioinformatics, and genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols
42 Consulting and research services in the fields of health care, medicine, life sciences, biotechnology, pharmaceuticals, bioinformatics, life sciences, genomics and pharmaceuticals and pharmaceutical safety for scientific research purposes; consulting and research services in the nature of retrieval, integration, correlation, analysis and interpretation of genomic, sequencing, and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, medical health information patient specific data, molecular test results, data from clinical studies, and scientific research for purposes of scientific, medical and pharmaceutical research; designing and developing searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and medical and health information and records, molecular test results and patient specific data about or relating to humans for scientific research purposes; providing temporary use to non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for purposes of scientific, medical and pharmaceutical research; providing temporary use to non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for purposes of scientific, medical and pharmaceutical research; providing temporary use to non-downloadable applications for mobile devices, namely, smart phones and tablets, and web applications accessible through the internet providing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology for scientific research purposes; data collection services for scientific research purposes in the fields of genomics, health care, pharmaceuticals, life sciences, bioinformatics, biotechnology and medicine; services for mobile devices, namely, smart phones and tablets, being software design; non-downloadable web applications for accessing databases accessible through the internet in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology; providing temporary use of non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; medical research services, namely, the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes
The mark consists of the words "MOLECULAR HEALTH" above the larger words "MH GUIDE", the "MH" being in stylized lettering consisting of vertical shapes.
Color is not claimed as a feature of the mark.
"MOLECULAR HEALTH GUIDE"

Trademark Events
Sep 18, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 18, 2018
Registered-Principal Register
Aug 17, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 16, 2018
Allowed Principal Register - Sou Accepted
Jul 24, 2018
Statement Of Use Processing Complete
Jul 11, 2018
Use Amendment Filed
Jul 11, 2018
Teas Statement Of Use Received
Jul 11, 2018
Teas Change Of Correspondence Received
Feb 21, 2018
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2018
Sou Extension 1 Granted
Jan 11, 2018
Sou Extension 1 Filed
Feb 20, 2018
Case Assigned To Intent To Use Paralegal
Feb 5, 2018
Notice Of Revival - E-Mailed
Feb 5, 2018
Sou Extension Received With Teas Petition
Feb 5, 2018
Petition To Revive-Granted
Feb 5, 2018
Teas Petition To Revive Received
Jul 11, 2017
Noa E-Mailed - Sou Required From Applicant
May 16, 2017
Official Gazette Publication Confirmation E-Mailed
May 16, 2017
Published For Opposition
Apr 26, 2017
Notification Of Notice Of Publication E-Mailed
Apr 6, 2017
Approved For Pub - Principal Register
Apr 5, 2017
Teas/Email Correspondence Entered
Apr 5, 2017
Correspondence Received In Law Office
Apr 5, 2017
Teas Response To Office Action Received
Mar 27, 2017
Notification Of Non-Final Action E-Mailed
Mar 27, 2017
Non-Final Action E-Mailed
Mar 27, 2017
Non-Final Action Written
Mar 16, 2017
Teas/Email Correspondence Entered
Mar 15, 2017
Correspondence Received In Law Office
Mar 15, 2017
Teas Response To Office Action Received
Sep 15, 2016
Notification Of Non-Final Action E-Mailed
Sep 15, 2016
Non-Final Action E-Mailed
Sep 15, 2016
Non-Final Action Written
Sep 8, 2016
Assigned To Examiner
Jun 2, 2016
Notice Of Design Search Code E-Mailed
Jun 1, 2016
New Application Office Supplied Data Entered
May 27, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24